Share |

Article Reprints

Many articles are available online through PubMed. For reprints of publications that are broader than those found on PubMed, please contact Jenni Krech to obtain a copy.

Publications

Minneapolis Heart Institute Professional Staff Published Articles
Publication (2009 – February 2010)

  1. Chung ES, Katra RP, Ghio S, Bax J, Gerritse B, Hilpisch K, Peterson BJ, Feldman DS, Abraham WT. Cardiac resynchronization therapy may benefit patients with left ventricular ejection fraction >35%: a PROSPECT trial substudy. Eur J Heart Fail. 2010 Feb 11.
  2. Corrado D, Pelliccia A, Heidbuchel H, Sharma S, Link M, Basso C, Biffi A, Buja G, Delise P, Gussac I, Anastasakis A, Borjesson M, Bjørnstad HH, Carrè F, Deligiannis A, Dugmore D, Fagard R, Hoogsteen J, Mellwig KP, Panhuyzen-Goedkoop N, Solberg E, Vanhees L, Drezner J, Estes NA 3rd, Iliceto S, Maron BJ, Peidro R, Schwartz PJ, Stein R, Thiene G, Zeppilli P, McKenna WJ; Section of Sports Cardiology, European Association of Cardiovascular Prevention and Rehabilitation; Working Group of Myocardial and Pericardial Disease, European Society of Cardiology. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J. 2010 Jan;31(2):243-59.
  3. Dib N, Menasche P, Bartunek JJ, Zeiher AM, Terzic A, Chronos NA, Henry TD, Peters NS, Fernández-Avilés F, Yacoub M, Sanborn TA, Demaria A, Schatz RA, Taylor DA, Fuchs S, Itescu S, Miller LW, Dinsmore JH, Dangas GD, Popma JJ, Hall JL, Holmes DR Jr. Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research. JACC Cardiovasc Interv. 2010 Mar;3(3):265-75.
  4. Hauser RG, Katsiyiannis WT, Gornick CC, Almquist AK, Kallinen LM. Deaths and cardiovascular injuries due to device-assisted implantable cardioverter-defibrillator and pacemaker lead extraction. Europace. 2010 Mar;12(3):395-401.
  5. Lu Z, Xu X, Hu X, Lee S, Traverse JH, Zhu G, Fassett J, Tao Y, Zhang P, Dos Remedios C, Pritzker M, Hall JL, Garry DJ, Chen Y. Oxidative Stress Regulates Left Ventricular PDE5 Expression in the Failing Heart. Circulation. 2010 Mar 22.
  6. Maron BJ. Dr. Gunnar Thor Gunnarsson and hypertrophic cardiomyopathy: what "giving back" means. Am J Cardiol. 2010 Jan 15;105(2):277-8.
  7. Maron BJ. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation. 2010 Jan 26;121(3):445-56.
  8. Maron BJ. National electrocardiography screening for competitive athletes: feasible in the United States? Ann Intern Med. 2010 Mar 2;152(5):324-6.
  9. Maron BJ. Sudden Cardiac Death in Genetic Heart Diseases and the Promise of Prevention. Rev Esp Cardiol. 2010 Mar;63(3):257-260.
  10. Maron BJ, Estes NA 3rd. Commotio cordis. N Engl J Med. 2010 Mar 11;362(10):917-27. Review.
  11. Philipp S, Böse D, Wijns W, Marso SP, Schwartz RS, König A, Lerman A, Garcia-Garcia HM, Serruys PW, Erbel R. Do systemic risk factors impact invasive findings from virtual histology? Insights from the international virtual histology registry. Eur Heart J. 2010 Jan;31(2):196-202.
  12. Sharkey SW, Windenburg DC, Lesser JR, Maron MS, Hauser RG, Lesser JN, Haas TS, Hodges JS, Maron BJ. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol. 2010 Jan 26;55(4):333-41.
  13. Simari RD, Moye LA, Skaralatos SI, Ellis SG, Zhao DXM, Willerson JT, Henry TD, Pepine CJ. Development of networks to test strategies in cardiovascular cell delivery: the NHLBI sponsored Cardiovascular Cell Therapy Research Network (CCTRN). J Cardiovasc Transl Res. 2010;3:30-6.
  14. Stehlik J, Feldman DS, Brown RN, Vanbakel AB, Russel SD, Ewald GA, Hagan ME, Folsom J, Kirklin JK; Cardiac Transplant Research Database Group. Interactions among donor characteristics influence post-transplant survival: A multi-institutional analysis. J Heart Lung Transplant. 2010 Mar;29(3):291-8.
  15. Thakkar BV, Hirsch AT, Satran D, Bart BA, Barness G, McCullough PA, Kennard ED, Kelsey SF, Henry TD. The efficacy and safety of enhanced external counterpulsation in patients with peripheral arterial disease. Vascular Medicine Vasc Med. 2010 Feb;15(1):15-20.
  16. Alberts MJ, Bhatt DL, Mas JL, Ohman EM, Hirsch AT, Röther J, Salette G, Goto S, Smith SC Jr, Liau CS, Wilson PW, Steg PG; REduction of Atherothrombosis for Continued Health Registry Investigators. Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. Eur Heart J. 2009 Oct;30(19):2318-26
  17. Bank AJ, Kaufman CL, Kelly AS, Burns KV, Adler SW, Rector TS, Goldsmith SR, Olivari MT, Tang C, Nelson L, Metzig A; PROMISE-CRT Investigators. Results of the Prospective Minnesota Study of ECHO/TDI in Cardiac Resynchronization Therapy (PROMISE-CRT) study. J Card Fail 2009;15(5):401-9. Collaborators: Goldsmith S, Mackedanz S, Gilliam J, Lundberg J, Metzig A, Nelson L, Snyder A, Adler A, Bank A, Dunbar D, Granrud G, Schenk T, Tindell L, Underwood D, Vatterott P, Almquist A, Burns R, Demmer P, Gornick C, Katsiyiannis B, Lawler C, Melby D, Olivari M, Tang C, Kopp D, Rahko P, Washburn M, Foster B, Tunio J, Zhu D, Lipinski P, Saleh N, Nemec J, Sturm S, Anand I, Doerfler K, Lectner S, Halvorsen S, Hustead S, Kramer M, Guerrero M, Burns K, Kaufman C, Kelly A, Rector T.
  18. Basso C, Thiene G, Mackey-Bojack S, Frigo AC, Corrado D, Maron BJ. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death. Eur Heart J. 2009 Jul; 30(13):1627-34.
  19. Baumgartner I, Chronos N, Comerota A, Henry T, Pasquet JP, Finiels F, Caron A, Dedieu JF, Pilsudski R, Delaère P. Local gene transfer and expression following intramuscular administration of FGF-1 plasmid DNA in patients with critical limb ischemia. Mol Ther 2009;17(5):914-21.
  20. Bjørnstad HH, Bjørnstad TH, Urheim S, Hoff PI, Smith G, Maron BJ. Long-term assessment of electrocardiographic and echocardiographic findings in Norwegian elite endurance athletes. Cardiology. 2009;112(3):234-41. Epub 2008 Aug 22. Erratum in: Cardiology. 2009;112(3):242.
  21. Bronas UG, Hirsch AT, Murphy T, Badenhop D, Collins TC, Ehrman JK, Ershow AG, Lewis B, Treat-Jacobson DJ, Walsh ME, Oldenburg N, Regensteiner JG. Design of the multicenter standardized supervised exercise training intervention for the 'CLaudication: Exercise Vs Endoluminal Revascularization (CLEVER) study'. Vasc Med. 2009 Nov;14(4):313-21
  22. Cacoub PP, Abola MT, Baumgartner I, Bhatt DL, Creager MA, Liau CS, Goto S, Röther J, Steg PG, Hirsch AT; REACH Registry Investigators. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis 2009;204(2):e86-92.
  23. Campbell AR, Satran D, Larson DM, Chavez IJ, Unger BT, Chacko BP, Decker J, Kapsner C, Henry TD. ST-elevation myocardial infarction: which patients do quality assurance programs include? Circ Cardiovasc Qual Outcomes 2009;2:648-655.
  24. Corrado D, Pelliccia A, Heidbuchel H, Sharma S, Link M, Basso C, Biffi A, Buja G, Delise P, Gussac I, Anastasakis A, Borjesson M, Bjørnstad HH, Carrè F, Deligiannis A, Dugmore D, Fagard R, Hoogsteen J, Mellwig KP, Panhuyzen-Goedkoop N, Solberg E, Vanhees L, Drezner J, Estes NA 3rd, Iliceto S, Maron BJ, Peidro R, Schwartz PJ, Stein R, Thiene G, Zeppilli P, McKenna WJ; On behalf of the Sections of Sports Cardiology of the European Association of Cardiovascular Prevention and Rehabilitation; and the Working Group of Myocardial and Pericardial Disease of the European Society of Cardiology. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J Eur Heart J. 2010 Jan;31(2):243-59.
  25. Eagle KA, Hirsch AT, Califf RM, Alberts MJ, Steg PG, Cannon CP, Brennan DM, Bhatt DL; on behalf of the REACH Registry Investigators. Cardiovascular Ischemic Event Rates in Outpatients With Symptomatic Atherothrombosis or Risk Factors in the United States: Insights From the REACH Registry. Crit Pathw Cardiol. 2009;8(2):91-7.
  26. Granada JF, Kaluza GL, Wilensky RL, Biedermann BC, Schwartz RS, Falk E. Porcine models of coronary atherosclerosis and vulnerable plaque for imaging and interventional research. EuroIntervention 2009 May;5(1):140-8
  27. Hara H, Virmani R, Holmes DR Jr, Buchbinder M, Lesser JR, Van Tassel RA, Mooney MR, Schwartz RS. Is the left atrial appendage more than a simple appendage? Catheter Cardiovasc Interv. 2009 Aug 1;74(2):234-42. Review.
  28. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB, Reisman MA, Schaer GL, Sherman W. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (Prochymalä) following acute myocardial infarction. J Am Coll Cardiol 2009;54:2277-2286.
  29. Harris KM, Pastorius CA, Duval S, Harwood E, Henry TD, Carabello BA, Hirsch AT. Practice variation among cardiovascular physicians in management of patients with mitral regurgitation. Am J Cardiol. 2009;103(2):255-61.
  30. Hauser RG. Preemption and malpractice liability. N Engl J Med 2009;360(21):2257-8; author reply 2258.
  31. Hauser RG. Monitoring an imperfect lead. Pacing Clin Electrophysiol. 2009;32(4):541-2.
  32. Hauser RG. Importance of ICD pulse generator longevity. Heart Rhythm 2009;6:1744.
  33. Hauser RG, Hayes DL. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. Heart Rhythm 2009;6(5):605-10.
  34. Hauser RG, Katsiyiannis WT, Gornick CC, Almquist AK, Kallinen LM. Deaths and cardiovascular injuries due to device-assisted implantable cardioverter-defibrillator and pacemaker lead extraction. Europace 2009 Nov 27. [Epub ahead of print].
  35. Henry TD. More than one leg to stand on: a step forward in the management of critical limb ischemia. Catheter Cardiovasc Interv 2009 Jul 1;74(1):20-1.
  36. Henry TD. A new option for the “no-option” patient with refractory angina? Catheter Cardiovasc Interv 2009;74:395-7.
  37. Henry TD, Larson DM. The ideal reperfusion strategy for the ST-elevation myocardial infarction patient with expected delay to percutaneous coronary intervention. Paradise lost or paradise renamed? JACC Cardiovasc Interv 2009;2:931-933.
  38. Henry TD, Wilson RF. Response to letter to the editor by Kovacic et al. Am Heart J 2009;157:e41.
  39. Ho CY, Carlsen C, Thune JJ, Havndrup O, Bundgaard H, Farrohi F, Rivero J, Cirino AL, Andersen PS, Christiansen M, Maron BJ, Orav EJ, Køber L. Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy. Circ Cardiovasc Genet. 2009 Aug;2(4):314-21.
  40. Holmes DR Jr, Schwartz RS. Left atrial appendage occlusion eliminates the need for warfarin. Circulation 2009;120:1919-1926; discussion 1926.
  41. Keo HH, Hirsch AT, Baumgartner I, Nikol S, Henry TD.Gene therapy in critical limb ischemia. Vascular Disease Management 2009;6:118-24.
  42. Knickelbine T, Lesser JR, Haas TS, Brandenburg ER, Gleason-Han BK, Flygenring B, Longe TF, Schwartz RS, Maron BJ. Identification of unexpected nonatherosclerotic cardiovascular disease with coronary CT angiography. JACC Cardiovasc Imaging. 2009 Sep;2(9):1085-92
  43. Kumar A, Fonarow GC, Eagle KA, Hirsch AT, Califf RM, Alberts MJ, Boden WE, Steg PG, Shao M, Bhatt DL, Cannon CP; REACH Investigators. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry. Crit Pathw Cardiol. 2009 Sep;8(3):104-11
  44. Lesser JR, Flygenring BJ, Knickelbine T, Longe T, Schwartz RS. Practical approaches to overcoming artifacts in coronary CT angiography. J Cardiovasc Comput Tomogr. 2009;3(1):4-15.
  45. Lim KK, Maron BJ, Knight BP. Successful catheter ablation of hemodynamically unstable monomorphic ventricular tachycardia in a patient with hypertrophic cardiomyopathy and apical aneurysm. J Cardiovasc Electrophysiol. 2009;20(4):445-7.
  46. Lovell M, Harris K, Forbes T, Twillman G, Abramson B, Criqui MH, Schroeder P, Mohler ER 3rd, Hirsch AT; Peripheral Arterial Disease Coalition. Peripheral arterial disease: lack of awareness in Canada. Can J Cardiol. 2009;25(1):39-45.
  47. Lutsey PL, Virnig BA, Durham SB, Steffen LM, Hirsch AT, Jacobs DR, Folsom AR. Correlates and Consequences of Venous Thromboembolism: The Iowa Women's Health Study. Am J Public Health. 2009 Nov 12. [Epub ahead of print].
  48. Madias C, Maron BJ, Alsheikh-Ali AA, Rajab M, Estes NA 3rd, Link MS. Precordial thump for cardiac arrest is effective for asystole but not for ventricular fibrillation. Heart Rhythm. 2009 Oct;6(10):1495-500.
  49. Maisel WH, Hauser RG, Hammill SC, Hauser RG, Ellenbogen KA, Epstein AE, Hayes DL, Alpert JS, Berger RD, Curtis AB, Dubin AM, Estes NA 3rd, Gura MT, Krahn AD, Lampert R, Lindsay BD, Wilkoff BL; Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines; American College of Cardiology (ACC); American Heart Association (AHA). Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines: developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm 2009;6(6):869-85.
  50. Maron BJ. Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening. Br J Sports Med. 2009 Sep;43(9):649-56.
  51. Maron BJ. Hypertrophic cardiomyopathy centers. Am J Cardiol. 2009 Oct 15;104(8):1158-9.
  52. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119(8):1085-92.
  53. Maron BJ, Doerer JJ, Haas TS, Estes NA, Hodges JS, Link MS. Commotio Cordis and the Epidemiology of Sudden Death in Competitive Lacrosse. Pediatrics. 2009 Aug 10. [Epub ahead of print]
  54. Maron BJ, Haas TS, Doerer JJ, Thompson PD, Hodges JS. Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am J Cardiol 2009 Jul 15;104(2):276-80.
  55. Maron BJ, Haas TS, Shannon KM, Almquist AK, Hodges JS. Long-term survival after cardiac arrest in hypertrophic cardiomyopathy. Heart Rhythm. 2009 Jul;6(7):993-7.
  56. Maron BJ, Ho CY. Hypertrophic cardiomyopathy without hypertrophy: an emerging pre-clinical subgroup composed of genetically affected family members. JACC Cardiovasc Imaging. 2009;2(1):65-8.
  57. Maron BJ, Lesser JR, Schiller NB, Harris KM, Brown C, Rehm HL. Implications of hypertrophic cardiomyopathy transmitted by sperm donation. JAMA. 2009 Oct 21;302(15):1681-4. Erratum in: JAMA 2009;302:1972.
  58. Maron BJ, Lever H. In defense of antimicrobial prophylaxis for prevention of infective endocarditis in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2009;54:2339-2340.
  59. Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, Biller L, Lesser JR, Udelson JE, Manning WJ, Appelbaum E. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol. 2009 Jul 14;54(3):220-8.
  60. Maron BJ, Maron MS, Wigle ED, Braunwald E. The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy. J Am Coll Cardiol. 2009 Jul 14;54(3):191-200.
  61. Maron MS, Olivotto I, Maron BJ, Prasad SK, Cecchi F, Udelson JE, Camici PG. The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2009 Aug 25;54(9):866-75
  62. Maron BJ, Roberts WC, Arad M, Haas TS, Spirito P, Wright GB, Almquist AK, Baffa JM, Saul JP, Ho CY, Seidman J, Seidman CE. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA. 2009;301(12):1253-9.
  63. Maron BJ, Seidman CE, Ackerman MJ, Towbin JA, Maron MS, Ommen SR, Nishimura RA, Gersh BJ. How should hypertrophic cardiomyopathy be classified?: What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy. Circ Cardiovasc Genet. 2009 Feb;2(1):81-5; discussion 86.
  64. Maron BJ, Semsarian C, Shen WK, Link MS, Epstein AE, Estes NA 3rd, Almquist A, Giudici MC, Haas TS, Hodges JS, Spirito P. Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy. Heart Rhythm 2009;6(5):599-602.
  65. Maron BJ, Spirito P. [Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM]. Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Apr;37(4):297-302. Chinese
  66. Matsumura JS, Katzen BT, Sullivan TM, Dake MD, Naftel DC; Excluder Bifurcated Endoprosthesis Investigators. Predictors of survival following open and endovascular repair of abdominal aortic aneurysms. Ann Vasc Surg. 2009;23(2):153-8.
  67. Meadows TA, Bhatt DL, Hirsch AT, Creager MA, Califf RM, Ohman EM, Cannon CP, Eagle KA, Alberts MJ, Goto S, Smith SC Jr, Wilson PW, Watson KE, Steg PG; on behalf of the REACH Registry Investigators. Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Am Heart J 2009;158:1038-1045.
  68. Menon M, Lesser JR, Hara H, Birkett R, Knickelbine T, Longe T, Flygenring B, Henry J, Schwartz R. Multidetector CT coronary angiography for patient triage to invasive coronary angiography: Performance and cost in ambulatory patients with equivocal or suspected inaccurate noninvasive stress tests. Catheter Cardiovasc Interv. 2009;73(4):497-502.
  69. Murphy TP, Hirsch AT, Cutlip DE, Regensteiner JG, Comerota AJ, Mohler E, Cohen DJ, Massaro J; on behalf of the CLEVER Investigators. Claudication: Exercise vs Endoluminal Revascularization (CLEVER) study update. J Vasc Surg. 2009 Oct;50(4):942-945.
  70. Newell MC, Doonan AL, Lesser JR, Schwartz RS. 3-d rotational angiography in the cardiac cath lab. J Invasive Cardiol 2009 Jul;21(7):336-8.
  71. Oderich GS, Bower TC, Sullivan TM, Bjarnason H, Cha S, Gloviczki P. Open versus endovascular revascularization for chronic mesenteric ischemia: risk-stratified outcomes. J Vasc Surg. 2009;49(6):1472-9.
  72. Olivotto I, DiDonna P, Baldi M, Sgalambro A, Maron BJ, Cecchi F. [Atrial fibrillation in hypertrophic cardiomyopathy: determinants, clinical course and management]. Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Apr;37(4):303-7. Chinese.
  73. Ormiston JA, Webster MW, Schwartz RS, Gladding P, Stewart JT, Kay IP, Ruygrok PN, Hatrick R. Feasibility, safety, and efficacy of a novel polymeric pimecrolimus-eluting stent: traditional pre-clinical safety end points failed to predict 6-month clinical angiographic results. JACC Cardiovasc Interv 2009;2:1017-1024.
  74. Philipp S, Böse D, Wijns W, Marso SP, Schwartz RS, König A, Lerman A, Garcia-Garcia HM, Serruys PW, Erbel R. Do systemic risk factors impact invasive findings from virtual histology? Insights from the international virtual histology registry. Eur Heart J. 2009 Oct 23. [Epub ahead of print].
  75. Schwartz RS, Burke A, Farb A, Kaye D, Lesser JR, Henry TD, Virmani R. Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathology. J Am Coll Cardiol 2009;5:2167-2173.
  76. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW; SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961-72. Collaborators: Mooney M, Kroshus T, Zijlstra F, Boonstra PW, Vermeersch P, Van Cauwelaert P, Glogar D, Grimm M, Den Heijer P, Vrakking MM, Stoler R, Henry AC, Zelman R, Rizzo R, Cannon LA, Vazales B, Koolen J, Schonberger JP, Carrié D, Fournial G, Eltchaninoff H, Bessou JP, Legrand V, Limet R, Marco J, Soula P, Berland J, Bessou JP, Darremont O, Fernandez G, Serruys PW, Kappetein AP, Feldman TE, Chedrawy E, Taussig A, Accola KD, Dobies D, Silver M, Gershlick AH, Spyt TJ, Horvath IG, Papp L, Wiemer M, Seifert D, Schuler G, Mohr FW, Santos Rodriguez I, Gonzalez Santos JM, Macaya C, Rodriguez E, Betriu A, Pomar JL, Ferreira C, Fragata J, Ruiz JM, Llamas PJ, Morice MC, Farge A, Ruzyllo W, Religa Z, Aschermann M, Tosovsky J, Bramucci E, d'Armini A, Suryapranata H, Bruinsma H, Bruinsma GJ, Presbitero P, Gallotti R, Berti S, Glauber M, Dudek D, Sadowski J, Banning A, Westaby S, Ho P, Chen J, Jensen J, Lockowandt U, Thomas MR, Desai JB, Boekstegers P, Reichart B, Hauptmann KE, Muller V, Rothman MT, MaGee P, Bode C, Beyersdorf F, Kellett MA, Kramer RS, Holmes DR, Schaff HV, Brown DL, Mack MJ, Edes I, Peterffy A, Drzewiecki J, Buszman P, Bochenek A, Hartmann F, Sievers H, Virtanen K, Harjula AL, Chang M, Kaplon R, Preda I, Tarr F, McGarry T, Lucas SK, de Bruyne B, Wellens F, Reimers B, Giacomin A, Guagliumi G, Ferrazzi P, Erglis A, Lacis R, Possati G, Crea F, Endresen K, Svennevig J, Minor R, Locher J, De Belder A, Forsyth A, Albertsson P, Wiklund L, Kiesz S, Otero C, Colombo A, Torracca L, Stine R, Azar H, Thuese L, Hostrup PN, Buckner K, Guber M, Wolschleger K, Heiser JC, Redwood S, Venn G, Suttorp M, van Boven WJ, Heyrich G, Deshpande A, Brown D, Seifert F, Heigert M, Unger F, Taeymans Y, Van Nooten G, Simon R, Cremer J, Meinertz T, Reichenspurner HC, Bocksch W, Rutsch W, Dohmen P, Dawkins KD, Livesey SA, James S, Stahle E, Olivecrona G, Ingemansson R, Horwitz P, Everett J, Mann T, Killinger W, Satler L, Boyce SW, Oldroyd KG, Berg G, Babikian VL, Birnbaum D, Carrel TP, Gorman M, Hanet C, Hess OM, Jansen EW, Kappelle LJ, Steg PG, Bassand JP, Clayton T, Faxon DP, Gersh BJ, Monro JL, Pocock S, Turina MI, Roy K, Pereda P.
  77. Sharkey SW, Maron BJ, Nelson P, Parpart M, Maron MS, Bristow MR. Adrenergic receptor polymorphisms in patients with stress (tako-tsubo) cardiomyopathy. J Cardiol. 2009;53(1):53-7.
  78. Sherrid MV, Cotiga D, Hart D, Ehlert F, Haas TS, Shen WK, Link MS, Estes NA 3rd, Epstein AE, Semsarian C, Daubert JP, Winters SL, Giudici MC, Maron BJ. Relation of 12-lead electrocardiogram patterns to implanted defibrillator-terminated ventricular tachyarrhythmias in hypertrophic cardiomyopathy. Am J Cardiol 2009;104:1722-1726.
  79. Slovut DP, Sullivan TM. Combined endovascular and open revascularization. Ann Vasc Surg 2009;23(3):414-24.
  80. Spirito P, Autore C, Rapezzi C, Bernabò P, Badagliacca R, Maron MS, Bongioanni S, Coccolo F, Estes NA, Barillà CS, Biagini E, Quarta G, Conte MR, Bruzzi P, Maron BJ. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation. 2009;119(13):1703-10.
  81. Spirito P, Maron BJ. [Risk stratification for sudden death in hypertrophic cardiomyopathy]. Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Apr;37(4):294-7. Chinese .
  82. Stehlik J, Feldman DS, Brown RN, Vanbakel AB, Russel SD, Ewald GA, Hagan ME, Folsom J, Kirklin JK; Cardiac Transplant Research Database Group. Interactions Among Donor Characteristics Influence Post-transplant Survival: A Multi-institutional Analysis. J Heart Lung Transplant. 2009 Oct 3. [Epub ahead of print].
  83. Thakkar BV, Hirsch AT, Satran D, Bart BA, Barness G, McCullough PA, Kennard ED, Kelsey SF, Henry TD. The efficacy and safety of enhanced external counterpulsation in patients with peripheral arterial disease. Vascular Medicine Vasc Med 2010 Feb;15(1):15-20.
  84. Traverse JH, Henry TD, Vaughn DE, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Piller LB, Penn MS, Byrne BJ, Perin EC, Gee AP, Hatzopoulos AK, McKenna DH, Forder JR, Taylor DA, Cogle CR, Olson RE, Jorgenson BC, Sayre SL, Vojvodic RW, Gordon DJ, Skarlatos SI, Moye' LA, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN). Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction. Am Heart J. 2009 Sep;158(3):356-63.
  85. Wykrzykowska JJ, Henry TD, Lesser JR, Schwartz RS. Imaging myocardial angiogenesis. Nat Rev Cardiol. 2009 Oct;6(10):648-58.
  86. Weimar C, Diener HC, Alberts MJ, Steg PG, Bhatt DL, Wilson PW, Mas JL, Röther J; REduction of Atherothrombosis for Continued Health Registry Investigators. The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry. Stroke. 2009;40(2):350-4.
  87. Wilson GJ, Nakazawa G, Schwartz RS, Huibregtse B, Poff B, Herbst TJ, Baim DS, Virmani R. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Circulation 2009;120:141-9.
  88. Wykrzykowska JJ, Henry TD, Lesser JR, Schwartz RS. Imaging myocardial angiogenesis. Nat Rev Cardiol. 2009 Oct;6(10):648-58.